Delivery of growth factors for tissue regeneration and wound healing

BioDrugs

Volumn 26, Issue 3, 2012, Pages 163-175

  Koria, Piyush ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Growth factors; Nanoparticles; Tissue replacements; Wound healing

Indexed keywords

AGAROSE; ALGINIC ACID; AUGMENT; BECAPLERMIN; BONE MORPHOGENETIC PROTEIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM PHOSPHATE; CARRAGEENAN; CHITOSAN; COLLAGEN SPONGE; ELASTIN; FIBRIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATIN; GEM 21S; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR; HYALURONIC ACID; INFUSE; KERATINOCYTE GROWTH FACTOR; OP 1; OSTEOGENIC PROTEIN 1; PALIFERMIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYLYSINE; SCATTER FACTOR; STARCH; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

APOPTOSIS; BONE REGENERATION; BURN; CELL DIFFERENTIATION; CELL METABOLISM; CELL MIGRATION; CERVICAL SPINE INJURY; CHEMOTAXIS; CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; DEGENERATIVE DISEASE; DIABETIC FOOT; DISEASE MODEL; DRUG DELIVERY SYSTEM; FRACTURE; HEART INFARCTION; HUMAN; HYDROGEL; LIGAMENT INJURY; LIVER CIRRHOSIS; LUNG INJURY; MOLECULAR MECHANICS; MUCOSA INFLAMMATION; MUSCLE DISEASE; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SILK; SKIN INJURY; SPINAL CORD INJURY; TISSUE GROWTH; TISSUE REGENERATION; ULCER; WOUND HEALING;

ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; GUIDED TISSUE REGENERATION; HUMANS; HYDROGELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NANOPARTICLES; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84860640298     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11631850-000000000-00000     Document Type: Review

References (142)

1. Xu X, Warrington AE, Bieber AJ, et al. Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network. CNS Drugs 2011 Jul; 25 (7): 555-73
2. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011 Dec 8; 365 (23): 2205-19
3. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010 Aug; 31 (24): 6279-308
4. Lanza R, Langer R, Vacanti J, et al. Principles of tissue engineering. 3rd ed. New York: Elsevier, 2007
5. Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol 2006 Jan; 24 (1): 4-8
6. Fukumitsu K, Yagi H, Soto-Gutierrez A. Bioengineering in organ transplantation: targeting the liver. Transplant Proc 2011 Jul-Aug; 43 (6): 2137-8
7. Margonar R, dos Santos PL,Queiroz TP, et al.Rehabilitation of atrophicmaxilla using the combination of autogenous and allogeneic bone grafts followed by protocol-type prosthesis. J Craniofac Surg 2010 Nov; 21 (6): 1894-6
8. Bukovcan P, Koller J. Treatment of partial-thickness scalds by skin xenografts: a retrospective study of 109 cases in a three-year period. Acta Chir Plast 2010; 52 (1): 7-12
9. Brydone AS, Meek D, Maclaine S. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng H 2010 Dec; 224 (12): 1329-43
10. Tompkins RG, Burke JF. Burn wound closure using permanent skin replacement materials. World J Surg 1992 Jan-Feb; 16 (1): 47-52
11. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011 Sep 30; 109 (8): 923-40
12. Nakahara T. Potential feasibility of dental stem cells for regenerative therapies: stem cell transplantation and whole-tooth engineering. Odontology 2011 Jul; 99 (2): 105-11
13. Baiguera S, D'Innocenzo B, Macchiarini P. Current status of regenerative replacement of the airway. Expert Rev Respir Med 2011 Aug; 5 (4): 487-94
14. Wezel F, Southgate J, Thomas DF. Regenerative medicine in urology. BJU Int 2011 Oct; 108 (7): 1046-65
15. Clark RA, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol 2007 May; 127 (5): 1018-29
16. Heddleston JM, Hitomi M, Venere M, et al. Glioma stem cell maintenance: the role of the microenvironment. Curr Pharm Des 2011; 17 (23): 2386-401
17. Agrawal V, Johnson SA, Reing J, et al. Epimorphic regeneration approach to tissue replacement in adultmammals. Proc Natl Acad SciUSA2010 Feb 23; 107 (8): 3351-5
18. Macri L, Clark RA. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 2009; 22 (2): 83-93
19. Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011 Feb 6; 8 (55): 153-70
20. Ladewig K. Drug delivery in soft tissue engineering. Expert Opin Drug Deliv 2011 Sep; 8 (9): 1175-88
21. Zhang S, Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009 Jul; 26 (7): 1561-80
22. Davidson JM. First-class delivery: getting growth factors to their destination. J Invest Dermatol 2008 Jun; 128 (6): 1360-2
23. Andreadis ST, Geer DJ. Biomimetic approaches to protein and gene delivery for tissue regeneration. Trends Biotechnol 2006 Jul; 24 (7): 331-7
24. Kobsa S, Saltzman WM. Bioengineering approaches to controlled protein delivery. Pediatr Res 2008 May; 63 (5): 513-9
25. Langer R. Drug delivery and targeting. Nature 1998 Apr 30; 392 (6679 Suppl): 5-10
26. Tayalia P, Mooney DJ. Controlled growth factor delivery for tissue engineering. Adv Mater 2009 Sep 4; 21 (32-33): 3269-85
27. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005 May; 90 (3): 315-26
28. Miki T, Bottaro DP, Fleming TP, et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 1992 Jan 1; 89 (1): 246-50
29. Miki T, Fleming TP, Bottaro DP, et al. Expression cDNA cloning of theKGF receptor by creation of a transforming autocrine loop. Science 1991 Jan 4; 251 (4989): 72-5
30. Gilbert E, Del Gatto F, Champion-Arnaud P, et al. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 1993 Sep; 13 (9): 5461-8
31. Han Q, Sun W, Lin H, et al. Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A 2009 Oct; 15 (10): 2927-35
32. Liu JJ, Wang CY,Wang JG, et al. Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning. J Biomed Mater Res A 2011 Jan; 96 (1): 13-20
33. Johnson PJ, Parker SR, Sakiyama-Elbert SE. Controlled release of neurotrophin- 3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng 2009 Dec 15; 104 (6): 1207-14
34. Fu YC, Nie H, Ho ML, et al. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng 2008 Mar 1; 99 (4): 996-1006
35. Fernandez-Montequin JI, Betancourt BY, Leyva-Gonzalez G, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. Int Wound J 2009 Feb; 6 (1): 67-72
36. Schultz CL, Morck DW. Contact lenses as a drug delivery device for epidermal growth factor in the treatment of ocular wounds. Clin Exp Optom 2010 Mar; 93 (2): 61-5
37. Kitamura M, Akamatsu M, Machigashira M, et al. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res 2011 Jan; 90 (1): 35-40
38. Kawaguchi H, Jingushi S, Izumi T, et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res 2007 Apr; 25 (4): 480-7
39. Ma B, Cheng DS, Xia ZF, et al. Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair Regen 2007 Nov-Dec; 15 (6): 795-9
40. Jansen RG, van Kuppevelt TH, Daamen WF, et al. FGF-2-loaded collagen scaffolds attract cells and blood vessels in rat oral mucosa. J Oral Pathol Med 2009 Sep; 38 (8): 630-8
41. Tatekawa Y, Kawazoe N, Chen G, et al. Tracheal defect repair using a PLGAcollagen hybrid scaffold reinforced by a copolymer stent with bFGFimpregnated gelatin hydrogel. Pediatr Surg Int 2010 Jun; 26 (6): 575-80
42. Kimura Y, Hokugo A, Takamoto T, et al. Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping. Tissue Eng Part C Methods 2008 Mar; 14 (1): 47-57
43. Wu JC, Huang WC, Chen YC, et al. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial. JNeurosurg Spine 2011 Sep; 15 (3): 216-27
44. Theiss HD, Brenner C, Engelmann MG, et al. Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial): rationale, design and first interim analysis. Int J Cardiol 2010 Nov 19; 145 (2): 282-4
45. Koch FP, Becker J, Terheyden H, et al.A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto beta-tricalcium phosphate for sinus lift augmentation. Clin Oral Implants Res 2010 Nov; 21 (11): 1301-8
46. Morishita R, Makino H, Aoki M, et al. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arterioscler Thromb Vasc Biol 2011 Mar; 31 (3): 713-20
47. Pulavendran S, Rose C, Mandal AB. Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice. J Nanobiotechnology 2011; 9: 15
48. Kishimoto Y, Hirano S,Kitani Y, et al. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel. Laryngoscope 2010 Jan; 120 (1): 108-13
49. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998 Jun; 9 (2): 153-65
50. Ray P. Protection of epithelial cells by keratinocyte growth factor signaling. Proc Am Thorac Soc 2005; 2 (3): 221-5
51. Jayakumar A, Rajababu P, Rohini S, et al. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with beta-tricalcium phosphate in human intra-osseous periodontal defects. J Clin Periodontol 2011 Feb; 38 (2): 163-72
52. Li B, Davidson JM, Guelcher SA. The effect of the local delivery of plateletderived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 2009 Jul; 30 (20): 3486-94
53. Sarkar A, Tatlidede S, Scherer SS, et al. Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice. Wound Repair Regen 2011 Jan; 19 (1): 71-9
54. Shen W, Chen X, Chen J, et al. The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials 2010 Oct; 31 (28): 7239-49
55. Grefte S, Kuijpers-Jagtman AM, Torensma R, et al. Skeletal muscle fibrosis: the effect of stromal-derived factor-1a-loaded collagen scaffolds. Regen Med 2010 Sep; 5 (5): 737-47
56. Park KH, Lee DH, Na K. Transplantation of poly(N-isopropylacrylamideco- vinylimidazole) hydrogel constructs composed of rabbit chondrocytes and growth factor-loaded nanoparticles for neocartilage formation. Biotechnol Lett 2009 Mar; 31 (3): 337-46
57. Park JS, Park K, Woo DG, et al. PLGA microsphere construct coated with TGF-beta 3 loaded nanoparticles for neocartilage formation. Biomacromolecules 2008 Aug; 9 (8): 2162-9
58. Hanft JR, Pollak RA, Barbul A, et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care 2008 Jan; 17 (1): 30-2, 4-7
59. Yang P, Wang C, Shi Z, et al. rhVEGF 165 delivered in a porous betatricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. J Biomed Mater Res A 2010 Feb; 92 (2): 626-40
60. Zhang H, Kamiya T, Hayashi T, et al. Gelatin-siloxane hybrid scaffolds with vascular endothelial growth factor induces brain tissue regeneration. Curr Neurovasc Res 2008 May; 5 (2): 112-7
61. Ye L, Zhang W, Su LP, et al. Nanoparticle based delivery of hypoxiaregulated VEGF transgene system combined with myoblast engraftment for myocardial repair. Biomaterials 2011 Mar; 32 (9): 2424-31
62. Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, et al. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 2011 Sep; 35 (9): 1271-80
63. Kitamura M, Nakashima K, Kowashi Y, et al. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS ONE 2008; 3 (7): e2611
64. Mulder G, Tallis AJ, Marshall VT, et al. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial. Wound Repair Regen 2009 Nov-Dec; 17 (6): 772-9
65. Fernandez-Montequin JI, Infante-Cristia E, Valenzuela-Silva C, et al. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int Wound J 2007 Dec; 4 (4): 333-43
66. SimonsM, Annex BH, LahamRJ, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002 Feb 19; 105 (7): 788-93
67. Fernandez-Montequin JI, Valenzuela-Silva CM, Diaz OG, et al. Intralesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J 2009 Dec; 6 (6): 432-43
68. Peres JA, Lamano T. Strategies for stimulation of new bone formation: a critical review. Braz Dent J 2011; 22 (6): 443-8
69. Zhang W, Wang X, Wang S, et al. The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 2011 Dec; 32 (35): 9415-24
70. Ishimatsu H, Kitamura C, Morotomi T, et al. Formation of dentinal bridge on surface of regenerated dental pulp in dentin defects by controlled release of fibroblast growth factor-2 from gelatin hydrogels. J Endod 2009 Jun; 35 (6): 858-65
71. Ishihara M, Fujita M, Obara K, et al. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth. Curr Drug Deliv 2006 Oct; 3 (4): 351-8
72. Henderson PW, Singh SP, Krijgh DD, et al. Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo. Wound Repair Regen 2011 May-Jun; 19 (3): 420-5
73. Jain A, Kim YT, McKeon RJ, et al. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials 2006 Jan; 27 (3): 497-504
74. Takeda K, Sakai N, Shiba H, et al. Characteristics of high-molecular-weight hyaluronic acid as a brain-derived neurotrophic factor scaffold in periodontal tissue regeneration. Tissue Eng Part A 2011 Apr; 17 (7-8): 955-67
75. Wu JC, Huang WC, Tsai YA, et al. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary phase I clinical study. J Neurosurg Spine 2008 Mar; 8 (3): 208-14
76. Bessa PC, Machado R, Nurnberger S, et al. Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J Control Release 2010 Mar 19; 142 (3): 312-8
77. Silva GA, Coutinho OP, Ducheyne P, et al. Starch-based microparticles as vehicles for the delivery of active platelet-derived growth factor. Tissue Eng 2007 Jun; 13 (6): 1259-68
78. Bouhadir KH, Lee KY, Alsberg E, et al. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 2001 Sep-Oct; 17 (5): 945-50
79. Hori K, Sotozono C, Hamuro J, et al. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release 2007 Apr 2; 118 (2): 169-76
80. TangDW, Yu SH, Ho YC, et al. Heparinized chitosan/poly(gamma-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials 2010 Dec; 31 (35): 9320-32
81. Park KH, Kim H, Na K. Neuronal differentiation of PC12 cells cultured on growth factor-loaded nanoparticles coated on PLGA microspheres. J Microbiol Biotechnol 2009 Nov; 19 (11): 1490-5
82. Patist CM, Mulder MB, Gautier SE, et al. Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials 2004 Apr; 25 (9): 1569-82
83. Wikesjo UM, Lim WH, Thomson RC, et al. Periodontal repair in dogs: evaluation of a bioabsorbable space-providing macroporous membrane with recombinant human bone morphogenetic protein-2. J Periodontol 2003 May; 74 (5): 635-47
84. Nie H, Soh BW, Fu YC, et al. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 2008 Jan 1; 99 (1): 223-34
85. Wang G, Kucharski C, Lin X, et al. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. J Drug Target 2010 Sep; 18 (8): 611-26
86. Mabilleau G, Aguado E, Stancu IC, et al. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture. Biomaterials 2008 Apr; 29 (11): 1593-600
87. Asamura S, Mochizuki Y, Yamamoto M, et al. Bone regeneration using a bone morphogenetic protein-2 saturated slow-release gelatin hydrogel sheet: evaluation in a canine orbital floor fracture model. Ann Plast Surg 2010 Apr; 64 (4): 496-502
88. Hayashi C, Hasegawa U, Saita Y, et al. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. J Cell Physiol 2009 Jul; 220 (1): 1-7
89. Hammond JS,Gilbert TW,HowardD, et al. Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol 2011 Feb; 54 (2): 279-87
90. Chu Y, Yu D, Wang P, et al. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats. Wound Repair Regen 2010 Sep-Oct; 18 (5): 499-505
91. Srouji S, Ben-David D, Lotan R, et al. Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. Tissue Eng Part A 2011 Feb; 17 (3-4): 269-77
92. Hosack LW, Firpo MA, Scott JA, et al. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials 2008 May; 29 (15): 2336-47
93. Yoon JJ, Chung HJ, Lee HJ, et al. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 2006 Dec 15; 79 (4): 934-42
94. Kang Derwent JJ, Mieler WF. Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. Trans Am Ophthalmol Soc 2008; 106: 206-13; discussion 13-4
95. Banerjee I, Mishra D, Das T, et al. Wound pH-responsive sustained release of therapeutics from a poly(NIPAAm-co-AAc) hydrogel. J Biomater Sci Polym Ed 2012; 23 (1-4): 111-32
96. Kim HK, Shim WS, Kim SE, et al. Injectable in situ-forming pH/thermosensitive hydrogel for bone tissue engineering. Tissue Eng Part A 2009 Apr; 15 (4): 923-33
97. Garbern JC, Minami E, Stayton PS, et al. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials 2011 Mar; 32 (9): 2407-16
98. Na K, Park JH, Kim SW, et al. Delivery of dexamethasone, ascorbate, and growth factor (TGF beta-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biomaterials 2006 Dec; 27 (35): 5951-7
99. Ehrbar M, Metters A, Zammaretti P, et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005 Jan 3; 101 (1-3): 93-109
100. Segers VF, Lee RT. Local delivery of proteins and the use of self-assembling peptides. Drug Discov Today 2007 Jul; 12 (13-14): 561-8
101. Zhao X, Zhang S. Designer self-assembling peptide materials. Macromol Biosci 2007 Jan 5; 7 (1): 13-22
102. Luo Z, ZhaoX, Zhang S. Self-organization of a chiralD-EAK16 designer peptide into a 3D nanofiber scaffold. Macromol Biosci 2008 Aug 11; 8 (8): 785-91
103. Koutsopoulos S, Unsworth LD, Nagai Y, et al. Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc Natl Acad Sci USA 2009 Mar 24; 106 (12): 4623-8
104. Saiga K, Furumatsu T, Yoshida A, et al. Combined use of bFGF and GDF-5 enhances the healing of medial collateral ligament injury. Biochem Biophys Res Commun 2010 Nov 12; 402 (2): 329-34
105. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, et al. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 2006 Dec; 27 (34): 5836-44
106. Genove E, Shen C, Zhang S, et al. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 2005 Jun; 26 (16): 3341-51
107. Koria P, Yagi H, Kitagawa Y, et al. Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc Natl Acad Sci USA 2011 Jan 18; 108 (3): 1034-9
108. Landsman A, Agnew P, Parish L, et al. Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis. J Am Podiatr Med Assoc 2010 May-Jun; 100 (3): 155-60
109. Yang Y, Xia T, Zhi W, et al. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. Biomaterials 2011 Jun; 32 (18): 4243-54
110. Fan H, Tao H, Wu Y, et al. TGF-beta3 immobilized PLGA-gelatin/ chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration. J Biomed Mater Res A 2010 Dec 15; 95 (4): 982-92
111. De la Riva B, Sanchez E, Hernandez A, et al. Local controlled release of VEGFandPDGFfrom a combined brushite-chitosan system enhances bone regeneration. J Control Release 2010 Apr 2; 143 (1): 45-52
112. Shi C, Chen W, Zhao Y, et al. Regeneration of full-thickness abdominal wall defects in rats using collagen scaffolds loaded with collagen-binding basic fibroblast growth factor. Biomaterials 2011 Jan; 32 (3): 753-9
113. Sun W, Lin H, Chen B, et al. Collagen scaffolds loaded with collagen-binding NGF-beta accelerate ulcer healing. J Biomed Mater Res A 2010 Mar 1; 92 (3): 887-95
114. Freeman I, Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009 Apr; 30 (11): 2122-31
115. Zhang L, Chen J, Han C. A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns. Wound Repair Regen 2009 Sep-Oct; 17 (5): 685-9
116. Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997 Dec; 68 (12): 1186-93
117. Kodama N, Nagata M, Tabata Y, et al. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. Bone 2009 Apr; 44 (4): 699-707
118. Rabbany SY, Pastore J, Yamamoto M, et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 2010; 19 (4): 399-408
119. Ratanavaraporn J, Furuya H, Kohara H, et al. Synergistic effects of the dual release of stromal cell-derived factor-1 and bonemorphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 2011 Apr; 32 (11): 2797-811
120. Takahashi Y, Yamamoto M, Yamada K, et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007 Feb; 13 (2): 293-300
121. Maire M, Chaubet F, Mary P, et al. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 2005 Aug; 26 (24): 5085-92
122. Srouji S, Rachmiel A, Blumenfeld I, et al. Mandibular defect repair by TGFbeta and IGF-1 released from a biodegradable osteoconductive hydrogel. J Craniomaxillofac Surg 2005 Apr; 33 (2): 79-84
123. Obara K, Ishihara M, Fujita M, et al. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2. Wound Repair Regen 2005 Jul-Aug; 13 (4): 390-7
124. Park J, Lim E, Back S, et al. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res A 2010 Jun 1; 93 (3): 1091-9
125. Luca L, Rougemont AL, Walpoth BH, et al. Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect. J Biomed Mater Res A 2011 Jan; 96 (1): 66-74
126. Kang SW, Kim JS, Park KS, et al. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone 2011 Feb; 48 (2): 298-306
127. Lee J, Choi WI, Tae G, et al. Enhanced regeneration of the ligament-bone interface using a poly(L-lactide-co-epsilon-caprolactone) scaffold with local delivery of cells/BMP-2 using a heparin-based hydrogel. Acta Biomater 2011 Jan; 7 (1): 244-57
128. Hayashi K, Kubo T, Doi K, et al. Development of new drug delivery system for implant bone augmentation using a basic fibroblast growth factor-gelatin hydrogel complex. Dent Mater J 2007 Mar; 26 (2): 170-7
129. Zieris A, Chwalek K, Prokoph S, et al. Dual independent delivery of proangiogenic growth factors from starPEG-heparin hydrogels. J Control Release 2011 Nov 30; 156 (1): 28-36
130. Moshfeghi AA, Peyman GA. Micro- and nanoparticulates. Adv Drug Deliv Rev 2005 Dec 13; 57 (14): 2047-52
131. Zhang J, Postovit LM, Wang D, et al. In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release. Nanoscale Res Lett 2009; 4 (11): 1297-302
132. Skaat H, Ziv O, Shahar A, et al. Enhancement of the growth and differentiation of nasal olfactory mucosa cells by the conjugation of growth factors to functional nanoparticles. Bioconjug Chem 2011 Dec 21; 22 (12): 2600-10
133. Chen FM, Ma ZW, Dong GY, et al. Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery. Acta Pharmacol Sin 2009 Apr; 30 (4): 485-93
134. Zavan B, Vindigni V, Vezzu K, et al. Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebocontrolled study. J Mater Sci Mater Med 2009 Jan; 20 (1): 235-47
135. d'Angelo I, Garcia-Fuentes M, Parajo Y, et al. Nanoparticles based on PLGA: poloxamer blends for the delivery of proangiogenic growth factors. Mol Pharm. Epub 2010 Aug 12
136. Park KH, Kim H, Moon S, et al. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J Biosci Bioeng 2009 Dec; 108 (6): 530-7
137. Vonau RL, Bostrom MP, Aspenberg P, et al. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res 2001 May; (386): 243-51
138. Ripamonti U, Crooks J, Petit JC, et al. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2: a pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci 2001 Aug; 109 (4): 241-8
139. Richardson TP, Peters MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001 Nov; 19 (11): 1029-34
140. Lim SM, Oh SH, Lee HH, et al. Dual growth factor-releasing nanoparticle/ hydrogel system for cartilage tissue engineering. J Mater Sci Mater Med 2010 Sep; 21 (9): 2593-600
141. Chen FM, Chen R, Wang XJ, et al. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 2009 Oct; 30 (28): 5215-24
142. Pastar I, Stojadinovic O, Krzyzanowska A, et al. Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med 2010 Mar; 16 (3-4): 92-101